LAKEISHA DAVIS: Open Payments
NPI 1629843214 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 39 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $924
Food & beverage: $924
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $254 |
| E.R. Squibb & Sons, L.L.C. | 8 | $195 |
| Otsuka America Pharmaceutical, Inc. | 8 | $191 |
| Janssen Pharmaceuticals, Inc | 3 | $67 |
| Neurocrine BioSciences, Inc. | 3 | $61 |
| ABBVIE INC. | 3 | $57 |
| Alkermes, Inc. | 3 | $56 |
| Lundbeck LLC | 2 | $44 |
Products named: CAPLYTA, COBENFY, REXULTI, INVEGA SUSTENNA, INGREZZA, VRAYLAR, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
